Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.
第一作者:
M,Barba
第一单位:
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, USA.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);血糖(Blood Glucose);乳腺肿瘤(Breast Neoplasms);结直肠肿瘤(Colorectal Neoplasms);无病生存(Disease-Free Survival);抗药性, 肿瘤(Drug Resistance, Neoplasm);禁食(Fasting);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);分子靶向治疗(Molecular Targeted Therapy);多元分析(Multivariate Analysis);比例危险度模型(Proportional Hazards Models);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)
DOI
10.1093/annonc/mdr540
PMID
22100694
发布时间
2024-03-22
- 浏览10
Annals of oncology
1838-45页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



